MarketFoolery

By The Motley FoolNews Business News

MarketFoolery episodes

January 17, 2017 Universal Stock Ideas
UnitedHealth Group’s 4th-quarter profits rise nearly 60%. Tiffany’s flagship store in NYC experiences a 14% drop in holiday sales. Analyst Jason Moser discusses Mattel’s new CEO and a few stock ideas he picked up during the long weekend he spent at Universal Studios.
25 min
January 16, 2017 Solar Power vs. Solar Technology
After a few months working in Germany analyst Matt Argersinger is back! We discuss how being in Germany affects the way he views the world of investing, why he thinks of solar as a technology (not a power), and why he’s keeping a close eye on Activision Blizzard (among others) this earnings season.
17 min
January 16, 2017 Solar Power vs. Solar Technology
After a few months working in Germany analyst Matt Argersinger is back! We discuss how being in Germany affects the way he views the world of investing, why he thinks of solar as a technology (not a power), and why he’s keeping a close eye on Activision Blizzard (among others) this earnings season.
17 min
January 12, 2017 Apple TV Gets Real
Apple’s reportedly planning to launch original TV shows and movies by the end of 2017. Analyst David Kretzmann discusses the opportunities and challenges the tech giant faces. To see more highlights and investing insights from David’s trip to CES go to http://CES.Fool.com.
24 min
January 12, 2017 Apple TV Gets Real
Apple’s reportedly planning to launch original TV shows and movies by the end of 2017. Analyst David Kretzmann discusses the opportunities and challenges the tech giant faces. To see more highlights and investing insights from David’s trip to CES go to http://CES.Fool.com.
24 min
January 11, 2017 “Dr. Watson will see you now.”
Gene-sequencing biotech Illumina soars on a new partnership with IBM’s Watson. Analyst Simon Erickson shares why he’s bullish on Illumina’s future. Plus, we discuss two increasingly competitive industries: groceries and restaurants.
18 min
January 11, 2017 “Dr. Watson will see you now.”
Gene-sequencing biotech Illumina soars on a new partnership with IBM’s Watson. Analyst Simon Erickson shares why he’s bullish on Illumina’s future. Plus, we discuss two increasingly competitive industries: groceries and restaurants.
18 min
January 10, 2017 Altaba Is The New Tronc
After Verizon closes the deal for Yahoo’s core assets, the leftover business will be renamed “Altaba”. Fool Funds analyst Bill Barker discusses Marissa Mayer’s track record as Yahoo’s CEO, signs of life from Chipotle, and how many stocks an individual should own.
24 min
January 10, 2017 Altaba Is The New Tronc
After Verizon closes the deal for Yahoo’s core assets, the leftover business will be renamed “Altaba”. Fool Funds analyst Bill Barker discusses Marissa Mayer’s track record as Yahoo’s CEO, signs of life from Chipotle, and how many stocks an individual should own.
24 min
January 09, 2017 Hello VW? It’s the FBI.
As the automakers gather in Detroit, the FBI arrests a senior Volkswagen executive. Analyst Jason Moser discusses why candy giant Mars would buy veterinary supply company VC. Plus, we offer a preview of earnings season.
26 min